By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eiger Biopharma 



Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Eiger Biopharma Announces FDA Fast Track Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 7/27/2017 6:37:19 AM
Eiger Biopharma Completes Enrollment In Phase II LIMT HDV Study Of Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 7/24/2017 6:20:15 AM
Eiger Biopharma Announces Sale Of Non-Strategic Assets To Theragene Pharmaceuticals 6/29/2017 8:59:07 AM
Eiger Biopharma Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA To Its Board Of Directors 6/14/2017 8:57:39 AM
Eiger Biopharma Reports Additional Positive Phase II Results From Multiple-Ascending Dose Study Of Exendin 9-39 In Post-Bariatric Hypoglycemia Patients At American Diabetes Association Meeting In San Diego 6/12/2017 6:51:40 AM
Eiger Biopharma Completes Enrollment In Phase II Multiple-Ascending Dose Study Of Exendin 9-39 In Post-Bariatric Hypoglycemia Patients 6/6/2017 7:23:43 AM
Eiger Biopharma Announces Results Demonstrating Benefit Of Ubenimex And Leukotriene B4 (LTB4) Modulation In Experimental Lymphedema 5/17/2017 6:55:13 AM
Eiger Biopharma Completes Enrollment Of Phase II LIBERTY Study Of Ubenimex In Pulmonary Arterial Hypertension 5/15/2017 6:31:54 AM
Eiger Biopharma Reports First Quarter 2017 Financial Results 5/12/2017 10:06:23 AM
Eiger Biopharma Announces Presentation Of Prevalence Data Of Hepatitis Delta Virus (HDV) Infection In The U.S. At Digestive Disease Week (DDW) In Chicago 5/8/2017 7:27:50 AM
1234567
//-->